Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
12.7K Views
•
10:39 min
•
April 15th, 2017
DOI :
April 15th, 2017
•Chapters in this video
0:05
Title
1:05
Engineering Heart Tissue (EHT) Generation
3:40
Contraction Analysis
5:48
Drug Screening
8:20
Results: Representative EHT Contraction Analysis
9:32
Conclusion
Related Videos
11:51
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
10.2K Views
10:37
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
6.3K Views
10:42
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
4.9K Views
08:03
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
1.7K Views
08:47
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
2.4K Views
08:07
Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
3.3K Views
12:28
Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
2.5K Views
07:42
Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
6.2K Views
06:17
3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells
334 Views
10:30
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
2.8K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved